AR
argenx SE
ARGNF · OTC
$1,010.26 +0.00% (+$0.00)
1M -0.56%
Market Cap $62.8B
P/E Ratio 46.72x
Div. Yield -
ROE 19.68%
Bulios Fair Price
$728.13
27.9% downside
Trenutna cena
$1,010
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ARGNF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
10 /100
Expensive P/FCF 71.72x
P/E 46.72x
P/B 8.58x
Growth
100 /100
Growing Book val. growth 37.56%
Rev. growth 113.97%
FCF growth N/A
Profitability
98 /100
Strong Op. margin 23.35%
Gross margin 89.14%
FCF margin 20.28%
Quality
78 /100
Excellent ROA 15.49%
ROIC 13.83%
Asset turnover 0.50x
Debt
100 /100
Low Int. coverage 237.50x
Debt/Equity 0.01x
Net debt/EBITDA -3.38x
Stability
18 /100
Unstable EPS volatility 166.16%
Beta -0.02x
Profitable years 2
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ARGNF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Karen Massey
Employees
1,863
Headquarters
Amsterdam
Prihajajoči dogodki
22 OKT.
Earnings
Upcoming earnings report
04 MAR.
Earnings
Upcoming earnings report